APEIRON Biologics AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: May 15, 2015
Pages: 25
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AF85AF35D41EN
Leaflet:

Download PDF Leaflet

APEIRON Biologics AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Apeiron Biologics AG (Apeiron) is a biotechnology company that focuses on the development of biological and immunological solutions for the treatment of various cancers. It carries out projects in the field of biotherapy and cancer immune. The company’s lead project, APN311, is an antibody-based therapy used for the treatment of high-risk neuroblastoma, a cancer in children. Apeiron’s other clinical development projects caters to the treatment of relapsed/refractory high-risk neuroblastoma and other cancers; diseases resulting from an imbalance in the renin angiotensin system (RAS), inflammatory skin conditions and cancer through modulation of the immuno-reactivity of T cells. Apeiron is headquartered in Vienna, Wein, Austria.

APEIRON Biologics AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
APEIRON Biologics AG, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deal Details
Asset Purchase
Apeiron Acquires Rights For Super Oxide Dismutase From Polymun
Partnerships
Evotec Enters Into Research Agreement With Apeiron Biologics For Cancer Immunotherapy
Evotec Enters Into Co-Development Agreement With APEIRON Biologics
Evotec Technologies Enters Into Collaboration With APEIRON Biologics
Licensing Agreements
Paladin Labs Enters Into Licensing Agreement With Apeiron Biologics For APN311
Apeiron Biologics Enters Into Licensing Agreement With CCRI And SIOPEN For CH14.18
APEIRON Biologics Enters Into Option Licensing Agreement With Cleveland Clinic
Apeiron Biologics Enters Into Licensing Agreement With Merck For Hu14.18-IL2
APEIRON Biologics Enters Into Licensing Agreement With GlaxoSmithKline
APEIRON Biologics AG - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Key Facts
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
APEIRON Biologics AG, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
APEIRON Biologics AG, Deals By Therapy Area, 2009 to YTD 2015
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Apeiron Acquires Rights For Super Oxide Dismutase From Polymun
Evotec Enters Into Research Agreement With Apeiron Biologics For Cancer Immunotherapy
Evotec Enters Into Co-Development Agreement With APEIRON Biologics
Evotec Technologies Enters Into Collaboration With APEIRON Biologics
Paladin Labs Enters Into Licensing Agreement With Apeiron Biologics For APN311
Apeiron Biologics Enters Into Licensing Agreement With CCRI And SIOPEN For CH14.18
APEIRON Biologics Enters Into Option Licensing Agreement With Cleveland Clinic
Apeiron Biologics Enters Into Licensing Agreement With Merck For Hu14.18-IL2
APEIRON Biologics Enters Into Licensing Agreement With GlaxoSmithKline
APEIRON Biologics AG, Key Competitors
APEIRON Biologics AG, Key Employees

LIST OF FIGURES
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
APEIRON Biologics AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Skip to top


Ask Your Question

APEIRON Biologics AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: